Adjuvant imatinib mesylate reduces risk of gastrointestinal stromal tumor recurrence

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2009年 / 9卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：555 / 555
页数：1
相关论文
共 50 条
  • [1] Risk Factors for Gastrointestinal Stromal Tumor Recurrence in Patients Treated With Adjuvant Imatinib
    Joensuu, Heikki
    Eriksson, Mikael
    Hall, Kirsten Sundby
    Hartmann, Joerg T.
    Pink, Daniel
    Schuette, Jochen
    Ramadori, Giuliano
    Hohenberger, Peter
    Duyster, Justus
    Al-Batran, Salah-Eddin
    Schlemmer, Marcus
    Bauer, Sebastian
    Wardelmann, Eva
    Sarlomo-Rikala, Maarit
    Nilsson, Bengt
    Sihto, Harri
    Ballman, Karla V.
    Leinonen, Mika
    DeMatteo, Ronald P.
    Reichardt, Peter
    CANCER, 2014, 120 (15) : 2325 - 2333
  • [2] Imatinib mesylate for the treatment of gastrointestinal stromal tumor
    Cassier, Philippe A.
    Blay, Jean-Yves
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (05) : 623 - 634
  • [3] Imatinib Mesylate: Targeted Therapy of Gastrointestinal Stromal Tumor
    Trent, Jonathan C.
    Dupart, Jheri
    Zhang, Wei
    CURRENT CANCER THERAPY REVIEWS, 2005, 1 (01) : 93 - 108
  • [4] Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate
    Ryu, MH
    Lee, JL
    Chang, HM
    Kim, TW
    Kang, HJ
    Sohn, HJ
    Lee, JS
    Kang, YK
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 36 (01) : 17 - 24
  • [5] A safety evaluation of imatinib mesylate in the treatment of gastrointestinal stromal tumor
    Ben Ami, Eytan
    Demetri, George D.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 571 - 578
  • [6] Patterns of progression in gastrointestinal stromal tumor treated with imatinib mesylate
    Ryu, M. H.
    Lee, J. L.
    Chang, H. M.
    Kim, T. W.
    Kang, H. J.
    Sohn, H. J.
    Lee, J. S.
    Kang, Y. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 346 - 346
  • [7] Approval Summary: Imatinib Mesylate in the Adjuvant Treatment of Malignant Gastrointestinal Stromal Tumors
    Cohen, Martin H.
    Cortazar, Patricia
    Justice, Robert
    Pazdur, Richard
    ONCOLOGIST, 2010, 15 (03): : 300 - 307
  • [8] ZNF-Mediated Resistance to Imatinib Mesylate in Gastrointestinal Stromal Tumor
    Rink, Lori
    Ochs, Michael F.
    Zhou, Yan
    von Mehren, Margaret
    Godwin, Andrew K.
    PLOS ONE, 2013, 8 (01):
  • [9] Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor
    Hou, Ying-Yong
    Zhou, Yang
    Lu, Shao-Hua
    Qi, Wei-Dong
    Xu, Cheng
    Hou, Jun
    Tan, Yun-Shan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (15) : 1910 - 1913
  • [10] Giant Gastrointestinal Stromal Tumor with Remarkable Preoperative Response to Imatinib Mesylate
    Stokes, Allen
    Herndon, Mark D.
    Conforti, Arnold M.
    AMERICAN SURGEON, 2010, 76 (08) : 903 - 904
12345